David Nierengarten
Stock Analyst at Wedbush
(4.85)
# 380
Out of 4,512 analysts
553
Total ratings
52.6%
Success rate
20.9%
Average return
Main Sectors:
Stocks Rated by David Nierengarten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COAG Hemab Therapeutics Holdings | Maintained: Buy | $42 → $55 | $43.31 | +26.99% | 3 | Jul 13, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Hold | $110 → $140 | $134.91 | +3.77% | 6 | Jul 6, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | $11 | $5.90 | +86.44% | 27 | Jun 30, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintained: Buy | $59 → $72 | $61.98 | +16.17% | 22 | Jun 29, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,000 | $859.43 | +16.36% | 57 | Jun 24, 2026 | |
| TCRX TScan Therapeutics | Maintained: Buy | $5 | $0.93 | +437.63% | 6 | Jun 23, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $135 | $133.96 | +0.78% | 14 | Jun 23, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $65 | $30.89 | +110.42% | 18 | Jun 22, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $80 → $100 | $98.95 | +1.06% | 9 | Jun 16, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $88 | $75.01 | +17.32% | 20 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $30.99 | +12.94% | 3 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $17.31 | +73.31% | 2 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $38.51 | +42.82% | 21 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $124 | $123.96 | +0.03% | 12 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.05 | +260.66% | 13 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $60 | $26.03 | +130.50% | 16 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 | $87.47 | +88.64% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $28.78 | +56.36% | 1 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $8.82 | +183.45% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $11 | $6.29 | +74.88% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $62.51 | +19.98% | 33 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $10.55 | +89.57% | 22 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 69.00 | $32.74 | +110.75% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $9.35 | +145.99% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 → $35 | $32.03 | +9.27% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $18 | $15.55 | +15.76% | 14 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $14.95 | +73.91% | 14 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $18.50 | n/a | 11 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $28.10 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.99 | n/a | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $22.59 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $53.78 | n/a | 15 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $6.02 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $3.47 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $4 | $10.01 | n/a | 23 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $34.81 | n/a | 5 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $48 → $16 | $101.28 | n/a | 8 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $11.16 | n/a | 6 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $68 → $53 | $13.30 | n/a | 14 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $32 | $4.29 | n/a | 11 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €310.80 → €305.54 | $762.30 | n/a | 2 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $10 | $0.0001 | n/a | 3 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $36 | $3.16 | n/a | 7 | Jun 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $527.39 | n/a | 1 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $13 | $8.64 | n/a | 2 | Apr 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $11.24 | n/a | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.711 | n/a | 1 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $5.16 | n/a | 6 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $13 | $3.98 | n/a | 6 | Oct 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.0001 | n/a | 7 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.9969 | n/a | 7 | Aug 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $38.17 | n/a | 3 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $9 | $2.07 | n/a | 4 | Nov 17, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $110.11 | n/a | 3 | Mar 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $21.80 | n/a | 1 | Mar 22, 2013 |
Hemab Therapeutics Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $42 → $55
Current: $43.31
Upside: +26.99%
ABIVAX Société Anonyme
Jul 6, 2026
Maintained: Hold
Price Target: $110 → $140
Current: $134.91
Upside: +3.77%
Nuvation Bio
Jun 30, 2026
Maintained: Buy
Price Target: $11
Current: $5.90
Upside: +86.44%
Kiniksa Pharmaceuticals International,
Jun 29, 2026
Maintained: Buy
Price Target: $59 → $72
Current: $61.98
Upside: +16.17%
argenx SE
Jun 24, 2026
Maintained: Buy
Price Target: $1,000
Current: $859.43
Upside: +16.36%
TScan Therapeutics
Jun 23, 2026
Maintained: Buy
Price Target: $5
Current: $0.93
Upside: +437.63%
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: $135
Current: $133.96
Upside: +0.78%
Beam Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $65
Current: $30.89
Upside: +110.42%
Spyre Therapeutics
Jun 16, 2026
Maintained: Buy
Price Target: $80 → $100
Current: $98.95
Upside: +1.06%
Disc Medicine
Jun 16, 2026
Maintained: Buy
Price Target: $88
Current: $75.01
Upside: +17.32%
Jun 16, 2026
Maintained: Buy
Price Target: $35
Current: $30.99
Upside: +12.94%
Jun 16, 2026
Maintained: Buy
Price Target: $30
Current: $17.31
Upside: +73.31%
Jun 15, 2026
Maintained: Buy
Price Target: $55
Current: $38.51
Upside: +42.82%
Jun 10, 2026
Downgraded: Hold
Price Target: $125 → $124
Current: $123.96
Upside: +0.03%
Jun 4, 2026
Maintained: Buy
Price Target: $11
Current: $3.05
Upside: +260.66%
May 18, 2026
Upgraded: Buy
Price Target: $22 → $60
Current: $26.03
Upside: +130.50%
May 14, 2026
Maintained: Buy
Price Target: $165
Current: $87.47
Upside: +88.64%
May 14, 2026
Maintained: Buy
Price Target: $45
Current: $28.78
Upside: +56.36%
May 13, 2026
Maintained: Buy
Price Target: $25
Current: $8.82
Upside: +183.45%
May 8, 2026
Maintained: Buy
Price Target: $8 → $11
Current: $6.29
Upside: +74.88%
Mar 31, 2026
Reiterated: Buy
Price Target: $75
Current: $62.51
Upside: +19.98%
Feb 24, 2026
Maintained: Buy
Price Target: $20
Current: $10.55
Upside: +89.57%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: kr 69.00
Current: $32.74
Upside: +110.75%
Dec 18, 2025
Maintained: Buy
Price Target: $23
Current: $9.35
Upside: +145.99%
Oct 14, 2025
Maintained: Hold
Price Target: $75 → $35
Current: $32.03
Upside: +9.27%
Oct 13, 2025
Maintained: Hold
Price Target: $27 → $18
Current: $15.55
Upside: +15.76%
Sep 2, 2025
Maintained: Buy
Price Target: $26
Current: $14.95
Upside: +73.91%
Jun 26, 2025
Maintained: Hold
Price Target: $8
Current: $18.50
Upside: n/a
May 23, 2025
Maintained: Buy
Price Target: $31 → $30
Current: $28.10
Upside: n/a
May 14, 2025
Maintained: Hold
Price Target: $5
Current: $2.99
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $33
Current: $22.59
Upside: n/a
Mar 17, 2025
Initiated Coverage: Buy
Price Target: $50
Current: $53.78
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $2
Current: $6.02
Upside: n/a
Apr 2, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $3.47
Upside: n/a
Jul 26, 2023
Maintained: Hold
Price Target: $9 → $4
Current: $10.01
Upside: n/a
Jul 12, 2023
Downgraded: Hold
Price Target: $4 → $2
Current: $34.81
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: $48 → $16
Current: $101.28
Upside: n/a
Jan 25, 2023
Maintained: Buy
Price Target: $19 → $17
Current: $11.16
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $68 → $53
Current: $13.30
Upside: n/a
Jun 16, 2021
Maintained: Buy
Price Target: $34 → $32
Current: $4.29
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: €310.80 → €305.54
Current: $762.30
Upside: n/a
Aug 7, 2020
Maintained: Hold
Price Target: $9 → $10
Current: $0.0001
Upside: n/a
Jun 18, 2019
Maintained: Buy
Price Target: $19 → $36
Current: $3.16
Upside: n/a
Aug 16, 2018
Reiterated: Buy
Price Target: $95
Current: $527.39
Upside: n/a
Apr 23, 2018
Maintained: Hold
Price Target: $55 → $13
Current: $8.64
Upside: n/a
Dec 21, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $11.24
Upside: n/a
Nov 28, 2017
Initiated Coverage: Buy
Price Target: $20
Current: $0.711
Upside: n/a
Oct 12, 2017
Reiterated: Buy
Price Target: $24 → $16
Current: $5.16
Upside: n/a
Oct 24, 2016
Reiterated: Hold
Price Target: $10 → $13
Current: $3.98
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.0001
Upside: n/a
Aug 3, 2016
Reiterated: Hold
Price Target: $2
Current: $0.9969
Upside: n/a
May 9, 2016
Maintained: Hold
Price Target: $4 → $3
Current: $38.17
Upside: n/a
Nov 17, 2015
Reiterated: Buy
Price Target: $16 → $9
Current: $2.07
Upside: n/a
Mar 31, 2014
Maintained: Sell
Price Target: n/a
Current: $110.11
Upside: n/a
Mar 22, 2013
Reiterated: Hold
Price Target: n/a
Current: $21.80
Upside: n/a